![](/img/cover-not-exists.png)
A Phase 1 Study of Afatinib in Combination with Postoperative Radiation Therapy with and Without Weekly Docetaxel in Intermediate- and High-Risk Patients with Resected Squamous Cell Carcinoma of the Head and Neck
Margalit, Danielle N., Haddad, Robert I., Tishler, Roy B., Chau, Nicole G., Schoenfeld, Jonathan D., Bakst, Richard L., Misiukiewicz, Krzysztof J., Gupta, Vishal, Posner, Marshall, Hanna, Glenn J., MaLanguage:
english
Journal:
International Journal of Radiation Oncology*Biology*Physics
DOI:
10.1016/j.ijrobp.2019.04.034
Date:
May, 2019
File:
PDF, 258 KB
english, 2019